Trial Profile
Conscious sedation for procedures in Dental and Minor Maxillofacial Surgery Unit: optimization of the dexmedetomidine dose (Dexdor).
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2020
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 01 Jun 2020 Status changed from recruiting to discontinued.
- 06 Nov 2014 New trial record